OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

September 20, 2009 BioBytes 102 - What are biomaterials?	September 4, 2009 BIO Media Briefing: Healthcare Reform Should Preserve Innovation	May 20, 2009 Tricia Brooks and James Trussell Discuss Stem Cell Research and Parkinson's Cures	April 5, 2009 Fernando Quesada Discusses Biotechnology in Mexico
March 9, 2009 The Importance of President Obama's Executive Order on Embryonic Stem Cells	February 25, 2009 Economic Impact of Advanced Biofuels	August 27, 2008 Biofuels Help Reduce Transportation Fuel Costs	August 15, 2008 Bloggers Discuss Biofuels